Tissue Repair & Recovery Research blend
KLOW 80 KLOW80
Repair, skin and inflammation blend
Research blend of BPC-157, GHK-Cu, TB-500 and KPV, an alpha-MSH-derived tripeptide, with proposed repair and anti-inflammatory pathways.
Evidence level. Evidence comes mainly from animal or other preclinical models. For a blend, the rating covers the combination itself; each component has its own profile. About the badges
- Class
- Repair, skin and inflammation blend
- Category
- Tissue Repair & Recovery
- Type
- Research blend
- Abbreviation
- KLOW80
- Development and regulatory status
- Not approved; research blend (BPC-157, GHK-Cu, TB-500, KPV)
Blend composition
What researchers study
Research blend of BPC-157, GHK-Cu, TB-500 and KPV (an alpha-MSH-derived tripeptide), combining proposed repair, matrix-remodelling and anti-inflammatory pathways. The components have been studied separately; no peer-reviewed data on the blend itself were located.
Research areas
- Combined repair, copper-peptide and anti-inflammatory pathway studies
- Gut and skin inflammation models (KPV component)
- Fibroblast and wound-healing assays
- Angiogenesis and cell-migration assays
Reported findings
Summaries of published results. Each one is tagged with the type of study behind it. They describe research outcomes and are not claims about any product. Why study type matters.
- literature search
No peer-reviewed study of this four-peptide blend was located, as evidence comes from the components studied separately
- rodent
In a 2024 mouse DSS-colitis study, a PepT1-targeted nanoparticle co-assembling KPV with FK506 reduced inflammatory cytokines and restored tight-junction proteins beyond KPV alone
- review
A review of Connectivity Map data reported GHK changed expression of 31.2% of human genes by at least 50%
Studied alongside
Compounds that appear together in research because their mechanisms complement each other, or as comparators. The reasons given are research reasoning, not recommendations for use.
